Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABOM

Staff Endocrinologist
TLC Diabetes and Endocrinology
University of British Columbia

Dr. Akshay Jain is the first Canadian physician to be triple board-certified by the American Boards in Endocrinology, Internal Medicine and Obesity Medicine.

He trained in Internal Medicine at Rochester, NY where he became the only 4-time winner of the prestigious Rochester Academy of Medicine Awards. He completed his Fellowship in Endocrinology at Harbor UCLA/City of Hope in Los Angeles, CA.

He is the only non-American physician to win the AACE Rising Star in Endocrinology Award (2022) and to feature on Medscape’s list of 25 Top Rising Stars of Medicine (2020). He is the first North American to win the prestigious Etzwiler Diabetes Scholarship at the International Diabetes Center and Mayo Clinic in MN, USA. In 2017, he was awarded the Rising Star of Diabetes Award at the International Symposium on Diabetes.

He is a renowned educator and has spoken at over 900 medical conferences/events across the world till date. He is a question-writer for the American Board of Obesity Medicine exams as well as for the Endocrine Society Self-Assessment Program (ESAP). He is a co-author of the 2023 Diabetes Canada Guidelines chapter on Mental Health and Diabetes.

His clinical interests include diabetes, obesity, thyroid disorders and osteoporosis.

He has active YouTube/Instagram channels dedicated to patient education with thousands of views till date.

He is fluent in 6 languages including English, Hindi, Gujarati, Marathi, Marwari and Urdu. In 2022, he won the Top 25 Canadian Immigrant Award, the Healthcare Achievement Award by Drishti Magazine and was also featured on The Peak’s list of Emerging Leaders of Canada- 2023.

Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Astra Zeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bausch Healthcare: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); CPD network: Speaker/Honoraria (Ongoing); Dexcom: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Speaker/Honoraria (Ongoing); Eisai: Speaker/Honoraria (Ongoing); gsk: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Consultant/Advisory Board (Ongoing); MDBriefcase: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Moderna: Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Partners in Progressive Medical Education: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); PocketPills: Consultant/Advisory Board (Ongoing); roche: Consultant/Advisory Board (Ongoing); Sandoz: Consultant/Advisory Board (Ongoing); sanofi aventis: Speaker/Honoraria (Ongoing); Takeda: Consultant/Advisory Board (Ongoing); Timed Right: Consultant/Advisory Board (Ongoing)

Presentation(s):